The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Tumor Ablation Therapy Devices Market Projected To Become By 2030 Based On Its 2026 Valuation?
The tumor ablation therapy devices market size has experienced rapid expansion in recent years. It is anticipated to increase from $0.82 billion in 2025 to $0.95 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.0%. Historically, this growth has been driven by increasing cancer incidence rates, the expansion of oncology treatment centers, the rising adoption of minimally invasive therapies, the availability of advanced imaging technologies, and a growing preference for organ-preserving treatments.
The tumor ablation therapy devices market size is projected to experience swift growth in the coming years. It is expected to reach $1.61 billion in 2030, showing a compound annual growth rate (CAGR) of 14.2%. This growth during the forecast period can be attributed to increasing investments in precision oncology, a rising demand for outpatient cancer treatments, the expansion of advanced ablation technologies, the growing integration of imaging and therapy systems, and an increasing focus on personalized cancer care. Key trends for the forecast period include the increasing adoption of minimally invasive tumor ablation procedures, the rising use of image-guided ablation systems, a growing demand for organ-specific ablation technologies, the expansion of percutaneous treatment approaches, and an enhanced focus on precision oncology.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp
What Primary Drivers Are Shaping The Development Of The Tumor Ablation Therapy Devices Market?
The rising incidence of cancer serves as a pivotal factor fueling the expansion of the tumor ablation therapy devices market. Globally, cancer stands as the second leading cause of death, responsible for approximately 1 in 6 deaths. This increasing prevalence is largely attributed to aging populations, as older individuals inherently face a greater lifetime risk of developing various forms of cancer. Tumor ablation, a minimally invasive treatment, sees widespread application for addressing tumors in the lung, liver, kidney, and bone. For example, the American Cancer Society Inc., a US-based non-profit health group, estimates 1,958,310 new cancer cases will be diagnosed in the US in 2023, marking an increase from the more than 1,918,030 new cases in 2022. Furthermore, this procedure presents an effective option for patients for whom chemotherapy or radiotherapy has been unsuccessful, consequently bolstering the growth of the tumor ablation therapy devices market.
What Segment Groups Are Identified Within The Tumor Ablation Therapy Devices Market?
The tumor ablation therapy devices market covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users
Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques
What Trends Are Advancing Progress In The Tumor Ablation Therapy Devices Market?
Leading companies in the tumor ablation therapy devices market are concentrating on advancing minimally invasive therapy to achieve a competitive advantage. This minimally invasive approach is applied for tumor ablation, delivering accurate and effective treatment with minimal damage to surrounding tissues. For example, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, obtained Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Vanquish minimally invasive water vapor ablation therapy. This initiative aims to accelerate the device’s development and simplify its regulatory evaluation, potentially enabling quicker patient access. Vanquish employs the thermal energy from a small quantity of sterile water to deliver precise treatments to cancerous tissue via a straightforward transurethral procedure. The therapy is crafted to destroy cancer cells while preserving nearby structures, thereby lessening the risk of severe side effects often linked with alternative prostate cancer treatments.
Which Companies Hold Significant Positions In The Tumor Ablation Therapy Devices Market?
Major companies operating in the tumor ablation therapy devices market are Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, Theraclion, INTIO Inc., Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Bovie Medical Corporation,
Read the full tumor ablation therapy devices market report here:
How Does The Tumor Ablation Therapy Devices Market Perform Across Major Global Regions?
North America was the largest region in the tumor ablation therapy devices market in 2025. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Tumor Ablation Therapy Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3351&type=smp
Browse Through More Reports Similar to the Global Tumor Ablation Therapy Devices Market 2026, By The Business Research Company
Tumor Ablation Market Report 2026
https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report
Oncology Ablation Market Report 2026
https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report
Ablation Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ablation-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model